TEVA PHARMACEUTICAL - SP ADR - US8816242

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q1 2014 · Compare: Q4 2013
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Polaris Capital Management, LLC History Added to 1,897,131 81,148 18.75% 15.13% 1 +386,100 25.55% Q1 2014 May 07, 2014